TherapeuticsMD, Inc. (TXMD )

Currency in USD Disclaimer
$1.71 -$0.25 (-12.76%)
Open 11/17/2025
$1.7
$2.1
$0.7
$2.44

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol TXMD
  • Company TherapeuticsMD, Inc.
  • Price $1.71
  • Changes Percentage -12.76
  • Change -0.25
  • Day Low $1.7
  • Day High $2.1
  • Year High $2.44
  • Year Low $0.7
  • Market Cap $20,023,646
  • Price Avg 50 EMA (D) $1.18
  • Price Avg 200 EMA (D) $1.13
  • Exchange NASDAQ
  • Volume 337,080
  • Average Volume 194,450
  • Open $1.96
  • Previous Close $1.96
  • EPS -0.05
  • PE -34.60
  • Earnings Announcement 2026-05-11 10:59:00
  • Shares Outstanding $11,574,362

Company brief: THERAPEUTICSMD, INC. (TXMD )

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TXMD Corporation News

Income Statement